Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014
- 758 Downloads
Bladder cancer (BC) represents a growing health care problem worldwide. In times of tight budgets and an aging society, new strategies for the transurethral treatment of BC are needed. Laser devices used for tumor vaporization and/or en bloc resection provide an alternative to parvenu strategies.
Materials and methods
Medline/Cochrane search was performed using following terms: bladder cancer, urothelial carcinoma, laser, en bloc, vaporization, photoablation, holmium, thulium, Ho:YAG, Tm:YAG, HoLRBT and TmLRBT. Last date of search was February 12, 2014.
Eighteen publications in English were identified including 800 patients (Ho:YAG = 652 patients and Tm:YAG = 148 patients). Data on en bloc resection techniques were presented in 10 publications, 7 publications provided data of tumor vaporization and one publication presented data on both. Level of evidence based on SIGN is mainly 3 (non-analytic studies); only three studies are level 2 (prospective case control studies). Tumor vaporization seems to be a promising alternative for the treatment of recurrent tumors in selected patients. It can be performed in an office-based approach without the need of general anesthesia. The use of photodynamic diagnostic might enhance surgical quality. The principle of en bloc resection should provide accurate staging in most cases; however, data on this important aspect are missing. Peri- and postoperative complications are scarce. Due to the nature of the energy source, bladder perforation caused by obturator nerve reflex is highly unlikely when using lasers. There is a trend toward decreased infield recurrence rates.
Lasers are potentially useful alternatives to conventional TURBT, but systematical assessments using standardized classification systems and well-designed RCTs are needed to make results comparable.
KeywordsLaser En bloc Vaporization Bladder cancer Holmium Thulium
Conflict of interest
The authors have no conflicts to declare in relation to this article.
- 11.Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653. doi: 10.1016/j.eururo.2013.06.003 CrossRefPubMedGoogle Scholar
- 12.Syed HA, Talbot N, Abbas A, MacDonald D, Jones R, Marr TJ, Rukin NJ (2013) Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia. J Endourol 27(7):886–891. doi: 10.1089/end.2012.0696 CrossRefPubMedGoogle Scholar
- 14.Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X, Xia S (2013) Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res 41(4):984–992. doi: 10.1177/0300060513477001 CrossRefPubMedGoogle Scholar
- 21.Soler-Martinez J, Vozmediano-Chicharro R, Morales-Jimenez P, Hernandez-Alcaraz D, Vivas-Vargas E, Santos Garcia-Vaquero I, Baena-Gonzalez V (2007) Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. J Urol 178(6):2337–2339. doi: 10.1016/j.juro.2007.08.034 CrossRefPubMedGoogle Scholar
- 25.Xishuang S, Deyong Y, Xiangyu C, Tao J, Quanlin L, Hongwei G, Jibin Y, Dongjun W, Zhongzhou H, Jianbo W, Lina W, Lin Y (2010) Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 24(1):69–73. doi: 10.1089/end.2009.0171 CrossRefPubMedGoogle Scholar
- 29.Wolters M, Kramer MW, Becker JU, Christgen M, Nagele U, Imkamp F, Burchardt M, Merseburger AS, Kuczyk MA, Bach T, Gross AJ, Herrmann TR (2011) Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol 29(4):429–432. doi: 10.1007/s00345-011-0686-z CrossRefPubMedGoogle Scholar
- 33.De Nunzio C, Franco G, Cindolo L, Autorino R, Cicione A, Perdona S, Falsaperla M, Gacci M, Leonardo C, Damiano R, De Sio M, Tubaro A (2014) Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol 40(1):90–95. doi: 10.1016/j.ejso.2013.11.003 CrossRefPubMedGoogle Scholar
- 34.Kramer MW, Abdelkawi IF, Wolters M, Bach T, Gross AJ, Nagele U, Conort P, Merseburger AS, Kuczyk MA, Herrmann TR (2014) Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer. Minim Invasive Ther Allied Technol. doi: 10.3109/13645706.2014.880065 PubMedGoogle Scholar